TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biorecro AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,210
|
2,870
|
2,050 |
| Financial expenses |
247
|
592
|
3 |
| Earnings before taxes |
84
|
-1,005
|
-54 |
| EBITDA |
302
|
-412
|
-51 |
| Total assets |
3,867
|
2,395
|
1,706 |
| Current assets |
372
|
2,395
|
1,706 |
| Current liabilities |
2,398
|
1,607
|
961 |
| Equity capital |
118
|
31
|
745 |
| - share capital |
52
|
48
|
50 |
| Employees (average) |
4
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
3.1%
|
1.3%
|
43.7% |
| Turnover per employee |
802
|
957
|
683 |
| Profit as a percentage of turnover |
2.6%
|
-35.0%
|
-2.6% |
| Return on assets (ROA) |
8.6%
|
-17.2%
|
-3.0% |
| Current ratio |
15.5%
|
149.0%
|
177.5% |
| Return on equity (ROE) |
71.2%
|
-3241.9%
|
-7.2% |
| Change turnover |
137
|
882
|
138 |
| Change turnover % |
4%
|
44%
|
7% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
33%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.